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Abstract Expression of the gene encoding resistin, a low
molecular weight protein secreted from adipose tissue postulated
to link obesity and type II diabetes, was examined in 3T3-L1
adipocytes. Resistin mRNA was detected in 3T3-L1 cells by day
3 following induction of differentiation into adipocytes; by day 4
the level of resistin mRNA peaked and remained high. The
PPARQ activators, rosiglitazone or darglitazone, reduced the
level of resistin mRNA. Dexamethasone upregulated resistin
mRNA level, but no effect was observed with the L3-adrenoceptor
agonist, BRL 37344. A substantial reduction in resistin mRNA
level was observed with insulin, which induced decreases at
physiological concentrations. Insulin may be a major inhibitor of
resistin production, and this does not support a role for resistin in
insulin resistance. ß 2001 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
Recent studies have indicated that white adipose tissue is an
endocrine and secretory organ, in addition to being the key
site of lipid storage in mammals [1^3]. White fat is in partic-
ular the most important source of the cytokine-like hormone,
leptin, there being a direct relationship between the amount of
body fat and the circulating level of this protein [4^6]. A wide
range of proteins factors are secreted from white adipose tis-
sue, including tumor necrosis factor (TNF)K, interleukin-6,
adiponectin, plasminogen activator inhibitor-1, angiotensino-
gen and acylation stimulating protein [1^3]. The most recent
secretory proteins to be identi¢ed from white fat are metal-
lothionein [7,8] and resistin [9]; both are low molecular weight
cysteine-rich proteins and resistin has been proposed as an
adipose-speci¢c hormone linking insulin resistance to obesity
[9].
Resistin was discovered as such during a screen for genes
which are downregulated in adipocytes by activators of the
PPARQ nuclear receptor [9]. The resistin gene is part of a
family of resistin-like molecules (RELMs) [10] which were
independently discovered as the FIZZ gene family, with
FIZZ3 being similar to resistin [11]. Resistin is also the
same as the cysteine-rich adipose tissue-speci¢c secretory fac-
tor (ADSF) [12]. No function was ascribed to FIZZ3, but as
ADSF it has been suggested that the protein acts as a feed-
back regulator of adipogenesis since it inhibits adipocyte dif-
ferentiation [12]. Thus two quite separate functions have been
proposed for the resistin/FIZZ3/ADSF protein (which we re-
fer to for simplicity as resistin).
Initial studies on the regulation of resistin production have
indicated that expression of the gene is reduced by fasting
[9,12] and there is a rapid increase in expression on refeeding
[12]. In addition, insulin has been reported to stimulate resis-
tin gene expression in streptozotocin-diabetic mice [12] and in
Zucker diabetic fatty rats [13]. It has also been reported that
the circulating resistin level is elevated in genetically obese
(ob/ob, db/db) and high fat-fed obese mice [9], but surprisingly
resistin mRNA levels in adipose tissue of di¡erent models of
obesity (ob/ob, db/db, tub/tub, KKAy) appear to be lower than
in lean littermates [13].
In the present study we have examined the regulation of
resistin gene expression in 3T3-L1 cells di¡erentiated into adi-
pocytes. The e¡ects of insulin, dexamethasone, a selective
L3-adrenoceptor agonist, forskolin and 8-bromo-cAMP have
been investigated. The response to a L3-agonist was of partic-
ular interest given the importance of the L3-adrenoceptor in
the control of lipolysis and of leptin production in rodent
adipose tissue [14^17], and in view of the recent suggestion
that isoprenaline inhibits resistin gene expression [18].
2. Materials and methods
2.1. Animals
Adult male mice (C57BL/6J-CBA, F2-hybrid) from the animal unit,
Faculty of Medicine, University of Oslo (Oslo, Norway) were killed
by cervical dislocation and the following tissues rapidly removed and
frozen in liquid N2 : interscapular brown fat, white adipose tissue
(epididymal, perirenal and subcutaneous depots), liver, heart, kidneys,
lungs, skeletal muscle (gastrocnemius) and the brain. The tissues were
stored at 370‡C. The mice were fed Rat and Mouse standard diet No.
1 (BpK Universal AS, Nittedal, Norway) containing approximately
19% protein and 5% fat.
2.2. Cell culture
3T3-L1 cells (American Type Culture Collection) were cultured at
37‡C in a humidi¢ed atmosphere of 5% CO2/95% air. The cells were
maintained in growth medium with the following constituents: Dul-
becco’s modi¢ed Eagle’s medium with 25 mM glucose (Sigma) con-
taining 10% heat inactivated foetal bovine serum (FBS) (Integro b.v.,
The Netherlands), 2 mM L-glutamine and 50 U/ml penicillin and 50
ng/ml streptomycin (Sigma). Di¡erentiation of the cells was initiated
2 days after con£uence by incubation for 3 days in growth medium
containing an additional 10% FBS, 1 WM dexamethasone, 0.5 mM
3-isobutyl-1-methyl-xanthine (Sigma) and 2 WM insulin. This was fol-
lowed by 3 days in growth medium containing 0.2 WM insulin (no
insulin thereafter). Di¡erentiated cells were given fresh growth me-
dium daily.
The cells were either maintained for up to 14 days after the induc-
tion of di¡erentiation, and sampled every 1^2 days, or for 8 days after
which time speci¢c agents were added and the cells harvested 48 h
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later. The following agents were employed: 8-bromo-cAMP (Sigma),
BRL 37344 (Tocris), dexamethasaone, forskolin (Sigma), insulin, dar-
glitazone and rosiglitazone. The cells were lysed in Trizol reagent
(Gibco BRL) and stored at 370‡C until analysis.
2.3. RNA preparation and Northern blot analysis
Total RNA was extracted from tissues and 3T3-L1 cells with Trizol,
as described by the manufacturer. Twenty Wg of the RNA was run on
1.4% agarose gels, blotted onto nylon membranes (Roche) by vacuum
blotting and hybridised, as previously described [19,20]. An antisense
oligonucleotide (5P-CGAATGTCCCACGAGCCACAGGCAGAGC-
CA) based on the mouse resistin cDNA sequence [9] was synthesised
as a hybridisation probe and end-labelled (5P-end) with a digoxigenin
ligand (Oswel DNA Services). Hybridisation signals were detected by
chemiluminescence using CDP-Star (Roche) as the substrate, with
membranes being exposed to ¢lm for up to 60 min. Signals were
analysed by densitometry using a Personal Densitometer scanner
and ImageQuant software (Molecular Dynamics Inc.).
After probing for resistin mRNA, blots were stripped and reprobed
for other mRNAs or for 18S rRNA. The sequence of the digoxigenin-
labelled antisense oligonucleotides used to detect ob, adipsin and lipo-
protein lipase mRNAs and 18S rRNA were as described previously
[19^21].
2.4. Data analysis
The e¡ect of di¡erent treatments was expressed relative to the con-
trols, which were assigned an arbitrary value of 100. The statistical
signi¢cance of di¡erences between groups was assessed using Stu-
dent’s t-test, with a threshold of P6 0.05.
3. Results
In initial studies, the expression of the resistin gene was
assessed in mouse tissues by Northern blotting using a speci¢c
antisense oligonucleotide probe for resistin mRNA. A strong
signal was obtained in each of the three white adipose tissue
sites examined (epididymal, perirenal and subcutaneous) and
there was no major di¡erence in the level of resistin mRNA
between these depots (Fig. 1). A very faint signal was discern-
ible with interscapular brown adipose tissue, but no signal was
detected in liver, brain, skeletal muscle, heart, kidney or the
lungs (Fig. 1). Strong expression was present in 3T3-L1 cells
examined at 12 days after the induction of di¡erentiation into
adipocytes (Fig. 1). A similar pattern of expression was evi-
dent for ob mRNA, except that a stronger signal was present
in brown fat and there was no signal with 3T3-L1 cells
(Fig. 1).
Resistin mRNA was not detected in undi¡erentiated 3T3-
L1 cells, but was evident by day 3 after the induction of
di¡erentiation into adipocytes (Fig. 2). A strong signal for
resistin mRNA was present at day 4 post-di¡erentiation and
the signal remained high over the following 8 days. A similar
pattern was evident with adipsin, a late marker of adipocyte
di¡erentiation, although at day 3 post-di¡erentiation a signal
for adipsin was barely detectable (Fig. 2). The level of lipo-
protein lipase mRNA was high by day 3 post-di¡erentiation
and thereafter.
The e¡ect of di¡erent agents on expression of the resistin
Fig. 1. Tissue speci¢city of resistin gene expression. Northern blot
of total RNA from mouse tissues and 3T3-L1 cells were probed se-
quentially for resistin mRNA, ob mRNA and 18S rRNA, using spe-
ci¢c antisense oligonucleotides. 20 Wg of total RNA were added to
each lane of the gel. The blots were stripped between hybridisations.
The 3T3-L1 cells were harvested at 12 days after the induction of
di¡erentiation. WAT, white adipose tissue; BAT, interscapular
brown adipose tissue; sk mus, skeletal muscle; gon, gonadal; peri,
perirenal; sc, subcutaneous.
Fig. 2. Induction of resistin gene expression during di¡erentiation of
3T3-L1 cells into adipocytes. Northern blot of total RNA from
3T3-L1 cells probed sequentially, before and after the induction of
di¡erentiation, for resistin mRNA, adipsin mRNA, lipoprotein
lipase mRNA and 18S rRNA, using speci¢c antisense oligonucleoti-
des. 20 Wg of total RNA were added to each lane of the gel. Di¡er-
entiation was initiated on day 0 and the numbers indicate the days
at which the cells were harvested.
Fig. 3. Resistin mRNA levels in 3T3-L1 adipocytes incubated with
PPARQ agonists. Cells were harvested at 8 days after the induction
of di¡erentiation and incubated for 48 h in media containing either
0.1 or 1 WM rosiglitazone (Ros-L and Ros-H, respectively) or dar-
glitazone (Dar-L and Dar-H, respectively). 20 Wg of total RNA
were added to each lane of the gels. Upper panel shows a represen-
tative Northern blot. Lower panel gives mean values þ S.E.M. (bars)
for groups of six. ***P6 0.001 compared with controls (Con).
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gene was examined between 8 and 10 days after the induction
of di¡erentiation when resistin mRNA levels were both high
and stable. Incubating 3T3-L1 adipocytes in media containing
speci¢c agonists of the PPARQ nuclear receptor resulted in a
marked inhibition of resistin gene expression. At concentra-
tions of 100 nM and 1 WM, rosiglitazone (BRL 49653) re-
duced the level of resistin mRNA by approximately 85%,
while similar concentrations of darglitazone led to reductions
of 90% (Fig. 3).
Resistin expression was not signi¢cantly a¡ected by 48 h
incubation with the selective L3-adrenoceptor agonist, BRL
37344 (50 nM or 1 WM), nor with 8-bromo-cAMP (Fig. 4).
The lack of e¡ect of BRL 37344 was also seen after 24 h of
treatment (results not shown). However, incubation with 2 or
10 WM forskolin signi¢cantly reduced resistin mRNA levels to
65 and 23% of control values, respectively (Fig. 4). In con-
trast, resistin mRNA levels were signi¢cantly increased, by
1.7- and 1.9-fold, after incubation with 2 and 20 nM dexa-
methasone, respectively (Fig. 4). Importantly, a substantial
reduction (s 4-fold) in resistin mRNA level was observed
with the addition of insulin (Fig. 4).
The amounts of insulin (1 and 10 WM) used in the experi-
ment in Fig. 4 were high. The e¡ect of adding di¡erent con-
centrations of insulin (from 0.2 to 4000 nM) was therefore
determined and the dose^response curve obtained is shown
in Fig. 5. The level of resistin mRNA was reduced by even
the lowest concentrations of insulin used, and fell by more
than half with the addition of a level of 6 nM or more, before
the e¡ect plateaued at 24% of the control value for the two
highest concentrations.
4. Discussion
The present study con¢rms, using a speci¢c 30-mer anti-
sense oligonucleotide, that the resistin gene is strongly ex-
pressed in white adipose tissue in mice. Expression was as
high in subcutaneous white fat as in the perirenal and epidi-
dymal depots. This contrasts with the ob gene where there are
large di¡erences between depots in the level of ob mRNA with
much higher expression occurring in the internal fat depots of
adult mice than in the subcutaneous sites [22].
The main aim of the present study was to investigate some
of the factors that regulate the expression of the resistin gene,
using 3T3-L1 adipocytes. Resistin mRNA was not detectable
by Northern blotting until 3 days after the induction of di¡er-
entiation of 3T3-L1 cells into adipocytes. Adipsin mRNA
appeared slightly later, indicating that expression of the resis-
tin gene is an earlier marker of adipocyte di¡erentiation than
the adipsin gene. From day 4 onwards the level of resistin
mRNA in the 3T3-L1 adipocytes remained high, as with adip-
sin. The high level of resistin mRNA in 3T3-L1 adipocytes
means that this clonal cell line can be used to investigate the
regulation of resistin gene expression.
Addition of the PPARQ activators, rosiglitazone and dargli-
tazone, led to a marked reduction in the level of resistin
mRNA in 3T3-L1 adipocytes, consistent with the initial ob-
servations which led to the identi¢cation of resistin [9]. How-
ever, a recent report has indicated that treatment with PPARQ
agonists leads to an increase rather than a decrease in resistin
mRNA in white adipose tissue of two types of obese animal,
ob/ob mice and Zucker rats [13]. A further paradox is that
while resistin mRNA is reported to be reduced in white fat
of various types of obese model [13], serum resistin levels
appear to be elevated [9].
Dexamethasone increased the level of resistin mRNA in
3T3-L1 adipocytes, indicating that glucocorticoids stimulate
the expression of the resistin gene, similar to their e¡ect on
ob gene expression and leptin production [21,23]. This obser-
vation is consistent with the induction of insulin resistance by
glucocorticoid excess [24]. The e¡ect of dexamethasone was
small, however, implying that glucocorticoids are not major
regulators of resistin production; furthermore, a report which
appeared during the preparation of the present paper found
no e¡ect of the synthetic glucocorticoid on resistin mRNA
Fig. 4. Resistin mRNA levels in 3T3-L1 adipocytes incubated with
various agents. Cells were harvested at 8 days after the induction of
di¡erentiation and incubated for 48 h in media containing either
BRL 37344 (50 nM, BRL-L; 1 WM, BRL-H), forskolin (2 WM, For-
L; 10 WM, For-H), 8-bromo-cAMP (cAMP-L, 2 WM; cAMP-H, 20
WM), insulin (1 WM, Ins-L; 10 WM, Ins-H) or dexamethasone (2 nM,
Dex-L; 20 nM, Dex-H). 20 Wg of total RNA were added to each
lane of the gels. Upper panel shows a representative Northern blot.
Lower panel gives mean values þ S.E.M. (bars) for groups of ¢ve.
*P6 0.05, **P6 0.01, ***P6 0.001 compared with controls (Con or
DMSO, according to whether DMSO was used as vehicle).
Fig. 5. Dose^response of the e¡ect of insulin on resistin mRNA lev-
el in 3T3-L1 cells. Cells were harvested at 8 days after the induction
of di¡erentiation and incubated for 48 h in media to which di¡erent
amounts of insulin were added. 0, no added insulin; 1, 0.2 nM;
2, 0.6 nM; 3, 2 nM; 4, 6 nM; 5, 20 nM; 6, 60 nM; 7, 200 nM;
8, 1000 nM; 9, 4000 nM insulin. 20 Wg of total RNA were added
to each lane of the gels. Values are the mean of two independent
experiments.
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level [18]. The same report suggested that the L-adrenoceptor
agonist, isoprenaline, inhibits resistin gene expression [18]. In
rodent adipose tissue, the dominant L-adrenoceptor in the
stimulation of lipolysis is the L3-subtype, and L3-adrenoceptor
agonists have a powerful inhibitory e¡ect on ob gene expres-
sion and leptin production in the tissue [14^17]. Nevertheless,
no response to the selective L3-agonist, BRL 37344, in terms
of resistin mRNA level, was found in 3T3-L1 adipocytes in
the present work. This suggests that any regulatory e¡ect of
catecholamines on resistin production does not operate
through L3-adrenoceptors.
The lack of response to a L3-adrenoceptor agonist implies
that the reported inhibitory e¡ect of isoprenaline on resistin
expression occurs via L1- or L2-adrenoceptors. However, we
have not found a signi¢cant e¡ect of isoprenaline on resistin
mRNA levels in 3T3-L1 adipocytes (control = 100; 1 WM iso-
prenaline = 79 þ 20; n = 5, Ps 0.1); nor was there any signi¢-
cant response to another L3-adrenoceptor agonist, CGP
12177. In these additional studies, 3T3-L1 adipocytes were
incubated with the L-adrenoceptor agonists for 24 h, rather
than for the 48 h used in the main experiments, and this is
closer to the 16 h period employed in the earlier report [18].
We also found no e¡ect on resistin mRNA levels of incuba-
tion with 8-bromo-cAMP, although there was a reduction
with forskolin. Overall, our results do not suggest a signi¢cant
role for catecholamines and the sympathetic system in the
regulation of resistin gene expression [17].
A marked suppressive e¡ect of insulin on resistin mRNA
levels in 3T3-L1 adipocytes was observed in the present study,
and this occurred with concentrations of insulin within and
below the physiological range. Thus insulin may be a key
regulator of resistin gene expression. In contrast to the direct
inhibitory e¡ect of insulin observed with 3T3-L1 cells, in vivo
studies have reported that insulin stimulates resistin gene ex-
pression in Zucker diabetic fatty rats [13] and in streptozoto-
cin-diabetic mice [12]. This apparent anomaly may re£ect, of
course, di¡erences between an adipocyte clonal cell line and
native white adipocytes, or between the direct and indirect
e¡ects of a hormone. Alternatively, pathological changes in
streptozotocin-induced diabetes and in diabetic fatty animals
may lead to abnormal responses to exogenous insulin.
Resistin has been independently discovered as FIZZ3 (a
member of the FIZZ gene family) [11] and as ADSF [12].
As resistin it was proposed that the protein is involved in
the induction of insulin resistance, linking obesity to diabetes
[9], while ADSF was considered to inhibit adipocyte di¡er-
entiation [12]. The inhibition by insulin of resistin gene ex-
pression in 3T3-L1 adipocytes is not consistent with a role for
resistin in the induction of insulin resistance, since high insulin
levels would be expected to stimulate production of a resis-
tance factor. On the other hand, if resistin/ADSF inhibits
adipocyte di¡erentiation and insulin suppresses resistin gene
expression, then rises in insulin would lead to the removal of a
brake on the production of new adipocytes. This would be an
appropriate response to the need to store excess nutrients,
particularly during the development of obesity.
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